Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alzheimer's disease.
ALZ | ST
Overview
Corporate Details
- ISIN(s):
- SE0007413455
- LEI:
- 549300K3IMVT20EK2S13
- Country:
- Sweden
- Address:
- Pepparedsleden 1, 431 83 MÖLNDAL
- Website:
- https://www.alzinova.com/
- Sector:
- Manufacturing
Description
Alzinova AB is a clinical-stage biopharmaceutical company specializing in the development of disease-modifying treatments for Alzheimer's disease. The company's approach is centered on its proprietary AβCC Peptide™ technology, which is used to develop immunotherapies that specifically target neurotoxic amyloid-beta oligomers, a primary cause of the disease. Alzinova's pipeline includes both active and passive immunotherapies. Its lead candidate, ALZ-101, is a therapeutic vaccine in clinical development designed to stimulate the patient's immune system to counteract the disease's progression, addressing a significant unmet medical need.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alzinova AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alzinova AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alzinova AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Other | 1,000,000 | 260,000.00 SEK |
| 2025-04-03 | Tord Evert Sigfried Labuda | Other | Buy | 10,000 | 18,800.00 SEK |
| 2025-04-02 | Tord Evert Sigfried Labuda | Other | Buy | 20,000 | 40,000.00 SEK |
| 2024-12-16 | Erik Kullgren | Other | Buy | 10,000 | 34,400.00 SEK |
Peer Companies
